vs
Side-by-side financial comparison of OFG BANCORP (OFG) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
OFG BANCORP is the larger business by last-quarter revenue ($184.3M vs $164.7M, roughly 1.1× PTC THERAPEUTICS, INC.). OFG BANCORP runs the higher net margin — 30.3% vs -82.0%, a 112.3% gap on every dollar of revenue. On growth, OFG BANCORP posted the faster year-over-year revenue change (0.9% vs -22.7%). OFG BANCORP produced more free cash flow last quarter ($199.3M vs $-36.6M). Over the past eight quarters, OFG BANCORP's revenue compounded faster (2.8% CAGR vs -11.5%).
OFG Bancorp, founded in 1964, is the financial holding company for Oriental Bank, located in San Juan, Puerto Rico. OFG offers a wide range of retail and commercial banking, lending and wealth management products, services and technology, primarily in Puerto Rico and the U.S. Virgin Islands through its principal subsidiaries: Oriental Bank, Oriental Financial Services LLC, and Oriental Insurance LLC. Its headquarters are located at Oriental Center, 254 Muñoz Rivera Avenue, San Juan, PR 00918....
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
OFG vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $184.3M | $164.7M |
| Net Profit | $55.9M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 25.7% | -43.3% |
| Net Margin | 30.3% | -82.0% |
| Revenue YoY | 0.9% | -22.7% |
| Net Profit YoY | 11.0% | -104.8% |
| EPS (diluted) | $1.27 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $184.3M | $164.7M | ||
| Q3 25 | $186.2M | $211.0M | ||
| Q2 25 | $182.4M | $178.9M | ||
| Q1 25 | $178.6M | $1.2B | ||
| Q4 24 | $182.7M | $213.2M | ||
| Q3 24 | $174.7M | $196.8M | ||
| Q2 24 | $179.8M | $186.7M | ||
| Q1 24 | $174.4M | $210.1M |
| Q4 25 | $55.9M | $-135.0M | ||
| Q3 25 | $51.8M | $15.9M | ||
| Q2 25 | $51.8M | $-64.8M | ||
| Q1 25 | $45.6M | $866.6M | ||
| Q4 24 | $50.3M | $-65.9M | ||
| Q3 24 | $47.0M | $-106.7M | ||
| Q2 24 | $51.1M | $-99.2M | ||
| Q1 24 | $49.7M | $-91.6M |
| Q4 25 | 25.7% | -43.3% | ||
| Q3 25 | 33.0% | 1.4% | ||
| Q2 25 | 36.1% | -19.5% | ||
| Q1 25 | 33.3% | 82.5% | ||
| Q4 24 | 28.9% | -76.2% | ||
| Q3 24 | 35.4% | -27.7% | ||
| Q2 24 | 39.6% | -21.5% | ||
| Q1 24 | 38.9% | -21.6% |
| Q4 25 | 30.3% | -82.0% | ||
| Q3 25 | 27.8% | 7.5% | ||
| Q2 25 | 28.4% | -36.3% | ||
| Q1 25 | 25.5% | 73.7% | ||
| Q4 24 | 27.6% | -30.9% | ||
| Q3 24 | 26.9% | -54.2% | ||
| Q2 24 | 28.4% | -53.1% | ||
| Q1 24 | 28.5% | -43.6% |
| Q4 25 | $1.27 | $-1.63 | ||
| Q3 25 | $1.16 | $0.20 | ||
| Q2 25 | $1.15 | $-0.83 | ||
| Q1 25 | $1.00 | $10.04 | ||
| Q4 24 | $1.10 | $-0.85 | ||
| Q3 24 | $1.00 | $-1.39 | ||
| Q2 24 | $1.08 | $-1.29 | ||
| Q1 24 | $1.05 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.0B | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.4B | $-205.3M |
| Total Assets | $12.5B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.0B | $1.9B | ||
| Q3 25 | $740.3M | $1.7B | ||
| Q2 25 | $851.8M | $2.0B | ||
| Q1 25 | $710.6M | $2.0B | ||
| Q4 24 | $591.1M | $1.1B | ||
| Q3 24 | $680.6M | $1.0B | ||
| Q2 24 | $740.4M | $1.1B | ||
| Q1 24 | $754.4M | $884.8M |
| Q4 25 | $1.4B | $-205.3M | ||
| Q3 25 | $1.4B | $-155.8M | ||
| Q2 25 | $1.3B | $-206.5M | ||
| Q1 25 | $1.3B | $-185.8M | ||
| Q4 24 | $1.3B | $-1.1B | ||
| Q3 24 | $1.3B | $-1.1B | ||
| Q2 24 | $1.2B | $-980.2M | ||
| Q1 24 | $1.2B | $-893.9M |
| Q4 25 | $12.5B | $2.9B | ||
| Q3 25 | $12.2B | $2.6B | ||
| Q2 25 | $12.2B | $2.6B | ||
| Q1 25 | $11.7B | $2.7B | ||
| Q4 24 | $11.5B | $1.7B | ||
| Q3 24 | $11.5B | $1.8B | ||
| Q2 24 | $11.3B | $1.9B | ||
| Q1 24 | $11.2B | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $217.7M | $-34.3M |
| Free Cash FlowOCF − Capex | $199.3M | $-36.6M |
| FCF MarginFCF / Revenue | 108.1% | -22.3% |
| Capex IntensityCapex / Revenue | 10.0% | 1.4% |
| Cash ConversionOCF / Net Profit | 3.90× | — |
| TTM Free Cash FlowTrailing 4 quarters | $345.4M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $217.7M | $-34.3M | ||
| Q3 25 | $39.5M | $-66.3M | ||
| Q2 25 | $35.9M | $-58.3M | ||
| Q1 25 | $83.1M | $870.1M | ||
| Q4 24 | $252.5M | $-30.0M | ||
| Q3 24 | $58.1M | $-77.0M | ||
| Q2 24 | $95.1M | $-71.5M | ||
| Q1 24 | $61.0M | $70.8M |
| Q4 25 | $199.3M | $-36.6M | ||
| Q3 25 | $35.5M | $-69.7M | ||
| Q2 25 | $31.8M | $-59.6M | ||
| Q1 25 | $78.7M | $868.4M | ||
| Q4 24 | $231.2M | $-33.8M | ||
| Q3 24 | $51.8M | $-77.5M | ||
| Q2 24 | $90.4M | $-78.8M | ||
| Q1 24 | $54.8M | $61.2M |
| Q4 25 | 108.1% | -22.3% | ||
| Q3 25 | 19.1% | -33.1% | ||
| Q2 25 | 17.4% | -33.3% | ||
| Q1 25 | 44.1% | 73.8% | ||
| Q4 24 | 126.5% | -15.8% | ||
| Q3 24 | 29.6% | -39.4% | ||
| Q2 24 | 50.3% | -42.2% | ||
| Q1 24 | 31.4% | 29.1% |
| Q4 25 | 10.0% | 1.4% | ||
| Q3 25 | 2.1% | 1.6% | ||
| Q2 25 | 2.3% | 0.7% | ||
| Q1 25 | 2.4% | 0.1% | ||
| Q4 24 | 11.7% | 1.8% | ||
| Q3 24 | 3.6% | 0.3% | ||
| Q2 24 | 2.6% | 4.0% | ||
| Q1 24 | 3.5% | 4.6% |
| Q4 25 | 3.90× | — | ||
| Q3 25 | 0.76× | -4.17× | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 1.82× | 1.00× | ||
| Q4 24 | 5.02× | — | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.86× | — | ||
| Q1 24 | 1.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
